Search by Drug Name or NDC
NDC 63323-0651-02 Adenosine 3 mg/mL Details
Adenosine 3 mg/mL
Adenosine is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is ADENOSINE.
Product Information
| NDC | 63323-0651 |
|---|---|
| Product ID | 63323-651_82a5c8e7-05d6-4f65-8677-af4426952dd7 |
| Associated GPIs | 35500010002015 35500010002020 94200005002010 |
| GCN Sequence Number | 013630 |
| GCN Sequence Number Description | adenosine VIAL 3 MG/ML INTRAVEN |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 35350 |
| HICL Sequence Number | 003734 |
| HICL Sequence Number Description | ADENOSINE |
| Brand/Generic | Generic |
| Proprietary Name | Adenosine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ADENOSINE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 3 |
| Active Ingredient Units | mg/mL |
| Substance Name | ADENOSINE |
| Labeler Name | Fresenius Kabi USA, LLC |
| Pharmaceutical Class | Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA077133 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63323-0651-02 (63323065102)
| NDC Package Code | 63323-651-02 |
|---|---|
| Billing NDC | 63323065102 |
| Package | 10 VIAL, SINGLE-USE in 1 TRAY (63323-651-02) / 2 mL in 1 VIAL, SINGLE-USE (63323-651-00) |
| Marketing Start Date | 2005-11-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |